DK1212039T3 - Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel - Google Patents

Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel

Info

Publication number
DK1212039T3
DK1212039T3 DK00957496T DK00957496T DK1212039T3 DK 1212039 T3 DK1212039 T3 DK 1212039T3 DK 00957496 T DK00957496 T DK 00957496T DK 00957496 T DK00957496 T DK 00957496T DK 1212039 T3 DK1212039 T3 DK 1212039T3
Authority
DK
Denmark
Prior art keywords
tetrahydrocannabinol
delta
semi
aqueous solvent
inhalation
Prior art date
Application number
DK00957496T
Other languages
English (en)
Inventor
Andrea M Mcphillips
Julia J Economou
Mahendra G Dedhiya
Beverly Ann Wynne
Original Assignee
Unimed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals Inc filed Critical Unimed Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1212039T3 publication Critical patent/DK1212039T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
DK00957496T 1999-08-20 2000-08-15 Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel DK1212039T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15002399P 1999-08-20 1999-08-20
PCT/US2000/022495 WO2001013886A1 (en) 1999-08-20 2000-08-15 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent

Publications (1)

Publication Number Publication Date
DK1212039T3 true DK1212039T3 (da) 2005-12-19

Family

ID=22532791

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00957496T DK1212039T3 (da) 1999-08-20 2000-08-15 Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel

Country Status (15)

Country Link
EP (1) EP1212039B1 (da)
JP (1) JP2003535813A (da)
CN (1) CN1187093C (da)
AT (1) ATE308314T1 (da)
AU (1) AU779324B2 (da)
CA (1) CA2382217A1 (da)
DE (1) DE60023720T2 (da)
DK (1) DK1212039T3 (da)
ES (1) ES2246883T3 (da)
HK (1) HK1056318A1 (da)
IL (2) IL148241A0 (da)
MX (1) MXPA02001804A (da)
NO (1) NO20020835L (da)
NZ (1) NZ517517A (da)
WO (1) WO2001013886A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US7648696B2 (en) 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
PT1280515E (pt) 2000-03-09 2007-04-30 Gw Pharma Ltd Compisoções farmacêuticas que compreendem canábis
GB2361869B (en) * 2000-03-09 2004-09-22 Pharmasol Ltd Sublingual delivery of cannabis
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
EP2314284B1 (en) * 2002-08-14 2017-02-15 GW Pharma Limited Cannabinoid liquid formulations for mucosal administration
CA2623723A1 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
GB2431105A (en) 2005-10-12 2007-04-18 Gw Pharma Ltd Cannabinoids for the treatment of pulmonary disorders
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
WO2015184127A2 (en) * 2014-05-29 2015-12-03 Insys Pharma, Inc. Stable cannabinoid formulations
US10610512B2 (en) 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
CN110200953B (zh) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 大麻素在制备吸入给药药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
WO2001013886A1 (en) 2001-03-01
CN1187093C (zh) 2005-02-02
EP1212039B1 (en) 2005-11-02
MXPA02001804A (es) 2004-09-06
AU779324B2 (en) 2005-01-20
JP2003535813A (ja) 2003-12-02
IL148241A0 (en) 2002-09-12
ATE308314T1 (de) 2005-11-15
CN1420761A (zh) 2003-05-28
NO20020835L (no) 2002-04-02
NZ517517A (en) 2004-03-26
HK1056318A1 (en) 2004-02-13
AU6910700A (en) 2001-03-19
CA2382217A1 (en) 2001-03-01
DE60023720T2 (de) 2006-07-20
ES2246883T3 (es) 2006-03-01
NO20020835D0 (no) 2002-02-20
IL148241A (en) 2007-02-11
EP1212039A1 (en) 2002-06-12
DE60023720D1 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
US4912124A (en) Antifungal dermatological solution
ES2120247T3 (es) Soluciones estables de budesonida, procedimiento para su preparacion, asi como empleo de estas soluciones como preparados para enemas y espumas farmaceuticas.
AR008927A1 (es) Una composicion farmaceutica que comprende una sustancia medicinalmente activa insoluble en agua con propiedades mejoradas de disolucion, absorcion, etc., y el procedimiento para prepararla
DK0877602T3 (da) Fremgangsmåde til fremstilling af pulverformede lungesurfactant-præparater
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
RU2003132426A (ru) Фармацевтический раствор арипипразола для орального применения
FI952842A (fi) Stabiloitu lääkeaerosolin liuosvalmiste
BRPI0509146B8 (pt) sistema de liberação de droga, método de fabricação do mesmo, e, uso do sistema de liberação de droga
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
CA2215327A1 (en) Formulations for lipophilic compounds
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
ATE228005T1 (de) Pharmazeutische formulierungen aus corticotropin freisetzenden faktor mit verbesserter stabilitaet in fluessiger form
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
AR034370A1 (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral
RU2002125493A (ru) Эндопаразитицидные средства
ES2174388T3 (es) Solucion liquida de medicamento para administracion oral.
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
DE69529079D1 (de) Codein enthaltende formulierungen
WO2002015866A3 (de) VERWENDUNG VON CYCLISCHEM 2,4 DIPHOSPHOGLYCERAT (cDGP) UND/ODER DERIVATEN IN KOSMETISCHEN UND DERMATOLOGISCHEN FORMULIERUNGEN
RU2003106170A (ru) Противопаразитарные препараты для безыгольного введения
ATE206048T1 (de) Zur topischen applikation bestimmte diclofenac- lösung
Ya'E et al. The effect and mechanism of new natural miticide camphor oil in killing Demodex